Caltech study eyes decade for powerful second-generation AIDS drug
Scientists at Caltech and partners report identification of the AIDS virus binding site on the CD4 receptor and the creation of decoy binding sites that could block infection. If developed, a second-generation drug might appear within about ten years, though caution urged by researchers and funders. The work, published in Science, could guide future antiviral agents and may aid other autoimmune disease therapies.
MENTIONED IN THIS ARTICLE
Pasadena
Cali
California Institute of Technology
Ortho
Ramtag
Nal
University of Alabama, Birmingham
Jameson
Stephen Bal
Kent
Krim
New York City
Caltech Biology
Leroy Hood
Alabama
Dan Capon
Genentech Inc
San Francisco
Also Mentioned on This Page
Mathilde Krim
American Foundation For Aids Research
Menem Et
Moorea Paints
Elyrio
Broad St. Elyria
Ohio
Elsen
Mee
Laci
Tite
Phu
Rai
Renee Ri
Rit Am
Mesvavass Pia
Lorain - Elyria - Oberlin
Lorain Senior Citizens Assoc
Midway Mall Information Booth
Lorain Chamber of Commerce
Elyria Chamber of Commerce
Oberlin Community Service Council
5Bs Transit Inc
Lorain County Transit System
West Eve Avenue
Broadway
P.m
Elyria
Aran Avenur
Keaton Thani
Avera
Oreraids
Midway Mall
Ohio Turnpike
Genith
Zenith
Orly Zenith
RCA
Diag
Kodak
Lorain